Variable selection when estimating effects in external target populations
- PMID: 38629587
- PMCID: PMC11299018
- DOI: 10.1093/aje/kwae048
Variable selection when estimating effects in external target populations
Abstract
External validity is an important part of epidemiologic research. To validly estimate effects in specific external target populations using a chosen effect measure (ie, "transport"), some methods require that one account for all effect measure modifiers (EMMs). However, little is known about how including other variables that are not EMMs (ie, non-EMMs) in adjustment sets affects estimates. Using simulations, we evaluated how inclusion of non-EMMs affected estimation of the transported risk difference (RD) by assessing the impacts of covariates that (1) differ (or not) between the trial and the target, (2) are associated with the outcome (or not), and (3) modify the RD (or not). We assessed variation and bias when covariates with each possible combination of these factors were used to transport RDs using outcome modeling or inverse odds weighting. Inclusion of variables that differed in distribution between the populations but were non-EMMs reduced precision, regardless of whether they were associated with the outcome. However, non-EMMs associated with selection did not amplify bias resulting from omission of necessary EMMs. Including all variables associated with the outcome may result in unnecessarily imprecise estimates when estimating treatment effects in external target populations.
Keywords: external validity; generalizability; odds weights; standardization; transportability.
© The Author(s) 2024. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health.
Conflict of interest statement
None declared.
Figures

Similar articles
-
When, why and how are estimated effects transported between populations? A scoping review of studies applying transportability methods.Eur J Epidemiol. 2025 Mar;40(3):255-273. doi: 10.1007/s10654-025-01217-w. Epub 2025 Apr 18. Eur J Epidemiol. 2025. PMID: 40249515 Free PMC article.
-
Using methods to extend inferences to specific target populations to improve the precision of subgroup analyses.J Clin Epidemiol. 2025 May;181:111716. doi: 10.1016/j.jclinepi.2025.111716. Epub 2025 Feb 7. J Clin Epidemiol. 2025. PMID: 39924128 Clinical Trial.
-
How Choice of Effect Measure Influences Minimally Sufficient Adjustment Sets for External Validity.Am J Epidemiol. 2023 Jul 7;192(7):1148-1154. doi: 10.1093/aje/kwad041. Am J Epidemiol. 2023. PMID: 36813295
-
Standardizing to specific target populations in distributed networks and multisite pharmacoepidemiologic studies.Am J Epidemiol. 2024 Jul 8;193(7):1031-1039. doi: 10.1093/aje/kwae015. Am J Epidemiol. 2024. PMID: 38412261 Free PMC article.
-
Impact of summer programmes on the outcomes of disadvantaged or 'at risk' young people: A systematic review.Campbell Syst Rev. 2024 Jun 13;20(2):e1406. doi: 10.1002/cl2.1406. eCollection 2024 Jun. Campbell Syst Rev. 2024. PMID: 38873396 Free PMC article. Review.
Cited by
-
When, why and how are estimated effects transported between populations? A scoping review of studies applying transportability methods.Eur J Epidemiol. 2025 Mar;40(3):255-273. doi: 10.1007/s10654-025-01217-w. Epub 2025 Apr 18. Eur J Epidemiol. 2025. PMID: 40249515 Free PMC article.
-
Redefining Representativeness of a Sample in Causal Terms.J Eval Clin Pract. 2025 Jun;31(4):e70137. doi: 10.1111/jep.70137. J Eval Clin Pract. 2025. PMID: 40545908 Free PMC article.
-
The AMerican PREGNANcy Mother-Child CohorT: description and prevalence of baseline outcomes and medication dispensing.Front Pharmacol. 2025 Aug 5;16:1608403. doi: 10.3389/fphar.2025.1608403. eCollection 2025. Front Pharmacol. 2025. PMID: 40837402 Free PMC article.
References
-
- Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. 3rd ed. Lippincott Williams & Wilkins; 2008.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous